| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-24143 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14179 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70570 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73213 | |||
![Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SESN1 antibody [HL1750] (NBP3-48662) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/nbp3-48662_rabbit-sesn1-mab-hl1750-western-blot-141120251826019.jpg "<b>Genetic Strategies Validation. </b>Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SESN1 antibody [HL1750] (NBP3-48662) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
![Immunohistochemistry-Paraffin: SNF5 Antibody (SMARCB1/4587R) [NBP3-13776] - Formalin-fixed, paraffin-embedded human sarcoma stained with SNF5 antibody (SMARCB1/4587R)](http://images.novusbio.com/fullsize/SNF5-Antibody-SMARCB1-4587R-Immunohistochemistry-Paraffin-NBP3-13776-img0001.jpg "Immunohistochemistry-Paraffin: SNF5 Antibody (SMARCB1/4587R) [NBP3-13776] - Formalin-fixed, paraffin-embedded human sarcoma stained with SNF5 antibody (SMARCB1/4587R)")
![Immunohistochemistry-Paraffin: SNF5 Antibody (SMARCB1/4587R) [NBP3-13776] - Formalin-fixed, paraffin-embedded human epithelioid sarcoma stained with SNF5 antibody (SMARCB1/4587R).](http://images.novusbio.com/fullsize/SNF5-Antibody-SMARCB1-4587R-Immunohistochemistry-Paraffin-NBP3-13776-img0002.jpg)
![Immunohistochemistry:[NBP3-29226]-Detection of human SMC1 by immunohistochemistry. Sample: FFPE section of human breast. Antibody: Affinity purified rabbit anti-SMC1.](http://images.novusbio.com/fullsize/nbp3-29226_rabbit-smc1-pab-2312025128832.jpg "Immunohistochemistry:[NBP3-29226]-Detection of human SMC1 by immunohistochemistry. Sample: FFPE section of human breast. Antibody: Affinity purified rabbit anti-SMC1.")
![Immunoprecipitation:DRG1 AntibodyNBP3-29837] -Detection of human DRG1 by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-DRG1 antibody NBP3-29837 (lot NBP3-29837-1) used for IP at 6 µg per reaction. DRG1 was also immunoprecipitated by rabbit anti-DRG1.. For blotting immunoprecipitated DRG1, NBP3-29837 was used at 1 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/nbp3-29837_rabbit-drg1-pab-301220241637312.jpg "Immunoprecipitation:DRG1 AntibodyNBP3-29837] -Detection of human DRG1 by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-DRG1 antibody NBP3-29837 (lot NBP3-29837-1) used for IP at 6 µg per reaction. DRG1 was also immunoprecipitated by rabbit anti-DRG1.. For blotting immunoprecipitated DRG1, NBP3-29837 was used at 1 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Immunohistochemistry:[NBP3-29326]-Detection of human Phospho SMC1 by immunohistochemistry. Samples: FFPE sections of human prostate carcinoma. Mock treatment or lambda phosphatase-treatment. Antibody: Affinity purified rabbit anti-Phospho-SMC1.](http://images.novusbio.com/fullsize/nbp3-29326_rabbit-smc1-pab-2312025129512.jpg "Immunohistochemistry:[NBP3-29326]-Detection of human Phospho SMC1 by immunohistochemistry. Samples: FFPE sections of human prostate carcinoma. Mock treatment or lambda phosphatase-treatment. Antibody: Affinity purified rabbit anti-Phospho-SMC1.")
![Western Blot: DHPS Antibody (2C9) [NBP2-02744] HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DHPS (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DHPS.](http://images.novusbio.com/fullsize/DHPS-Antibody-2C9-Western-Blot-NBP2-02744-img0001.jpg "Western Blot: DHPS Antibody (2C9) [NBP2-02744] HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DHPS (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DHPS.")
![Western Blot: EBP1 Antibody (1D3) [NBP2-00981] HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY EBP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-EBP1.](http://images.novusbio.com/fullsize/EBP1-Antibody-1D3-Western-Blot-NBP2-00981-img0001.jpg "Western Blot: EBP1 Antibody (1D3) [NBP2-00981] HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY EBP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-EBP1.")
![Western Blot: E2F6 Antibody [NBP1-46117] - NBP1-46117 (1ug/ml) staining of Human Skeletal Muscle lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/E2F6-Antibody-Western-Blot-NBP1-46117-img0002.jpg "Western Blot: E2F6 Antibody [NBP1-46117] - NBP1-46117 (1ug/ml) staining of Human Skeletal Muscle lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: HIC1 Antibody [NBP2-26159] - Staining of Mouse Testes lysate (35 ug protein in RIPA buffer). Antibody at 2 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/HIC1-Antibody-Western-Blot-NBP2-26159-img0001.jpg "Western Blot: HIC1 Antibody [NBP2-26159] - Staining of Mouse Testes lysate (35 ug protein in RIPA buffer). Antibody at 2 ug/mL. Detected by chemiluminescence.")
![Western Blot: FRA-1/FOSL1 Antibody [NB100-40803] - (1ug/ml) staining of Human Bone Marrow lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/FRA-1-FOSL1-Antibody-Western-Blot-NB100-40803-img0003.jpg "Western Blot: FRA-1/FOSL1 Antibody [NB100-40803] - (1ug/ml) staining of Human Bone Marrow lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: FHL3 Antibody [NBP1-26395] - (1ug/ml) Western blot analysis of Human Skeletal Muscle lysate (35ug protein in RIPA buffer) using NBP1-26395 at 1ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/FHL3-Antibody-Western-Blot-NBP1-26395-img0002.jpg "Western Blot: FHL3 Antibody [NBP1-26395] - (1ug/ml) Western blot analysis of Human Skeletal Muscle lysate (35ug protein in RIPA buffer) using NBP1-26395 at 1ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.")